AnaptysBio, Inc. (NASDAQ: ANAB) reported Q2 EPS of ($1.34), $0.18 better than the analyst estimate of ($1.52). Revenue for the quarter came in at $22.26 million versus the consensus estimate of $11.51 million.

For earnings history and earnings-related data on AnaptysBio, Inc. (ANAB) click here.